German Industry Wants To Simplify 'Complicated' Switch Process

 
• By David Ridley

The German Medicines Manufacturers´ Association, the BAH, is calling for the country's prescription-to-OTC reclassification procedure to be simplified by removing from the process the country's Ministry of Health and Bundesrat, and empowering the medicines agency, BfArM, to make the final decision based on recommendations from the Expert Advisory Committee for Prescription. 

Munich, Germany skyline at City Hall.
Munich's Neue Rathaus Features A Glockenspiel In The Tower Balcony • Source: Shutterstock

Germany’s procedure for switching medicines from prescription-only to OTC status is “too complicated, non-transparent and unpredictable” and should be “modernized,” according to the German Medicines Manufacturers´ Association, the BAH.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health